Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for nonalcoholic fatty liver disease

Affiliations

Comment

Juerg Reichen. ACP J Club. 2006 Jan-Feb.

. 2006 Jan-Feb;144(1):22.

No abstract available

Comment on

The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. Adams LA, et al. Gastroenterology. 2005 Jul;129(1):113-21. doi: 10.1053/j.gastro.2005.04.014. Gastroenterology. 2005. PMID: 16012941

Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for non-alcoholic fatty liver disease.
Reichen J. Reichen J. Evid Based Med. 2006 Feb;11(1):26. doi: 10.1136/ebm.11.1.26. Evid Based Med. 2006. PMID: 17213068 No abstract available.
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S, Anania FA. Parekh S, et al. Gastroenterology. 2007 May;132(6):2191-207. doi: 10.1053/j.gastro.2007.03.055. Gastroenterology. 2007. PMID: 17498512 Review.
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. Fan JG, et al. J Gastroenterol Hepatol. 2007 Jul;22(7):1086-91. doi: 10.1111/j.1440-1746.2006.04781.x. J Gastroenterol Hepatol. 2007. PMID: 17608855
Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
Wong VW, Hui AY, Tsang SW, Chan JL, Wong GL, Chan AW, So WY, Cheng AY, Tong PC, Chan FK, Sung JJ, Chan HL. Wong VW, et al. Aliment Pharmacol Ther. 2006 Oct 15;24(8):1215-22. doi: 10.1111/j.1365-2036.2006.03112.x. Aliment Pharmacol Ther. 2006. PMID: 17014580
Recent advances in nonalcholic fatty liver disease.
Greenfield V, Cheung O, Sanyal AJ. Greenfield V, et al. Curr Opin Gastroenterol. 2008 May;24(3):320-7. doi: 10.1097/MOG.0b013e3282fbccf2. Curr Opin Gastroenterol. 2008. PMID: 18408460 Review.